Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Earlybird Venture"


3 mentions found


German aerospace company Lilium wants to revolutionize air travel with its electric vertical take-off and landing (eVTOL) jet. "Revolutionize means make it absolutely zero emission," Lilium CEO Klaus Roewe told CNBC Tech in an interview. "We want to make a regional plane that has a decent transport capacity to have a meaningful effect on CO2 emission reduction." Less than a decade after being founded by four university students, the group is now one of Europe's leading eVTOL companies. Lilium, which is backed by the likes of China's Tencent and Earlybird Venture Capital, has started taking orders from the premium market.
Persons: Klaus Roewe, Lilium, Roewe, China's, Daniel Wiegand, Lilium's, Wiegand Organizations: CNBC Tech, Earlybird Venture, eVTOL Aircraft Locations: Weßling, Bavaria
Rights holders argue that AI using their work without a license should be considered "unauthorized derivative work" — an infringement of copyright law. Meanwhile, AI startups insist that their models comply with fair-use doctrine, which grants them some leeway to others' works. This month, Universal Music Group sued the AI startup Athropic for circulating copyrighted lyrics. He believes that future regulations may explicitly forbid AI data scraping. "They can train models on data that's not universally available to customers, and tell them it's licensed and compliant."
Persons: Eva Toorenent, who's, that's, Simon Menashy, Menashy, Ekaterina Almasque, OpenOcean Almasque, Getty, Sunny Dhillon, Harvey, Horowitz, Andre Retterath, GDPR, CCPA, Taylor, Swift Organizations: Universal Music Group, Getty, Harvard Business, MMC Ventures, Kyber Knight Capital, Nvidia, Earlybird Venture Locations: what's, Europe
Big Pharma and biotech companies often outsource clinical trials to external companies. Europe's early-stage clinical trials startups are flush with funds but they're struggling to grow. The fate — and market cap — of a biotech company often lies with a successful clinical trial. The COVID-19 pandemic also spotlighted another promising alternative to carry out these trials — startups. While the US touts around a dozen clinical trials unicorns valued at $1 billion or higher, per Dealroom estimates, Europe's startups are lagging behind.
Persons: BEN, Janssen, Christoph Ruedig, Maya Zlatanova, Europe hasn't, Matt Wilson, Wilson, Christoph Massner, it's, Ruedig Organizations: Big Pharma, pharma, Janssen Pharmaceuticals, Tempus, Venture, Albion VC, US, Earlybird Ventures Locations: Europe, New York, American
Total: 3